Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
View Patent ↗The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R 1 and R 2 , are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
1. A compound of the formula,
wherein:
R 10 and R 11 are each independently selected from hydrogen and C 1 -C 10 alkyl, provided that both R 10 and R 11 are not hydrogen; or
R 10 and R 11 , together with the atom to which they are attached, form a C 3 -C 6 cycloalkly group; and
R 4a , R 4b , R 4c , and R 4d are each independently selected from hydrogen, halo, C 1 -C 10 alkyl, —CF 3 , and —OCH 3 , provided that R 4b and R 4c are not both hydrogen.
2. A compound according to claim 1 , wherein R 4a and R 4d are each hydrogen, and R 4b and R 4c are each independently selected from hydrogen, halo, C 1 -C 10 alkyl, and —CF 3 .
3. A compound according to claim 2 , wherein R 4b and R 4c are independently hydrogen or halo.
4. A compound according to claim 3 , wherein R 4b is fluorine or chlorine, and R 4c is hydrogen.
5. A compound according to claim 1 , wherein R 10 and R 11 are C 1 -C 10 alkyl.
6. A compound according to claim 5 , wherein R 10 and R 11 are —CH 3 .
7. A compound according to 5 , wherein R 4a and R 4d are each hydrogen, and R 4b and R 4c are independently selected from hydrogen, halo, C 1 -C 10 alkyl, and —CF 3 , provided that R 4b and R 4c are not both hydrogen.
8. A compound according to claim 7 , wherein R 4b and R 4c are independently hydrogen or halo, provided that R 4b and R 4c are not both hydrogen.
9. A compound according to claim 8 , wherein R 4b is fluorine or chlorine, and R 4c is hydrogen.
10. A compound according to claim 1 , selected from:
2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-2-methyl-propionitrile;
1-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-cyclopropanecarbonitrile;
1-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-cyclobutanecarbonitrile;
2-{4-[2-(2-cyclopentyl-4,6-dioxotetrahydro-2H-pyran-2-yl) ethyl]-2-fluorop-henyl}-2-methylpropanenitrile;
2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-2ethyl-butyronitrile;
1-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-cyclopropanecarbonitrile;
2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2,6-difluorophenyl}-2-methyl-propionitrile;
2-{2-chloro-4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]p-henyl}-2-methyl-propionitrile;
1-{2-chloro-4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-phenyl}-cyclopropanecarbonitrile;
1-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-cyclopentanecarbonitrile;
2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2-fluorophenyl}-propionitrile;
1-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl) -ethyl]-2,6-difluorophenyl}-cyclopropanecarbonitrile;
and 2-{4-[2-(2-cyclopentyl-4,6-dioxo-tetrahydro-pyran-2-yl)-ethyl]-2,6-difluorophenyl}-2-ethyl-butyronitrile.
11. A compound according to claim 1 , selected from (+)-2-{4-[2(2-cyclopentyl-4,6-dioxotetrahydro-2H-pyran -2-yl)ethyl]-2-fluorophenyl}-2-methylpropanenitrile and (−)-2-{4-[2-(2-cyclopentyl-4,6-dioxotetrahydro-2H-pyran-2-yl)ethyl]-2-fluorophenyl}-2-methylpropanenitrile.
12. A compound of the formula,
wherein:
R 10 and R 11 are each independently selected from hydrogen and C 1 -C 10 alkyl, provided that both R 10 and R 11 are not hydrogen; or
R 10 and R 11 , together with the atom to which they are attached, form a C 3 -C 10 cycloalkyl group; and
R 4a and R 4d are each independently selected from hydrogen, halo, C 10 -C 10 alkyl, —CF 3 , and —OCH 3 ;
R 4b is fluorine or chlorine; and
R 4c is hydrogen.
13. A compound according to claim 12 , wherein R 4a and R 4d are each hydrogen.
14. A compound of the formula,
wherein R 10 and R 11 are C 1 -C 10 alkyl; and
R 4a , R 4b , R 4c , and R 4d are each independently selected from hydrogen, halo, C 1 -C 10 alkyl, —CF 3 , and —OCH 3 , provided that R 4b and R 4c are not both hydrogen.
15. A compound according to 14 , wherein R 4a and R 4d are each hydrogen, and R 4b and R 4c are independently selected from hydrogen, halo, C 1 -C 10 alkyl, and —CF 3 , provided that R 4b and R 4c are not both hydrogen.
16. A compound according to claim 15 , wherein R 4b and R 4c are independently hydrogen or halo, provided that R 4b and R 4c are not both hydrogen.
17. A compound according to claim 16 , wherein R 4b is fluorine or chlorine, and R 4c is hydrogen.
18. A compound according to claim 17 , selected from:
2-(4-bromo-2-fluorophenyl)-2-methylpropionitrile;
1-(4-bromo-2-fluorophenyl)-cyclopropanecarbonitrile;
2-(4-bromo-2-fluorophenyl)-2-ethylbutyronitrile;
1-(4-bromo-2-fluorophenyl)-cyclobutanecarbonitrile;
2-(4-bromo-2-fluorophenyl)-2-methylpropanenitrile;
2-(4-bromo-2-fluorophenyl)-2-ethylbutyronitrile;
1-(4-bromo-2-fluorophenyl)-cyclopropanecarbonitrile;
2-(4-bromo-2,6-difluorophenyl)-2-methylpropionitrile;
2-(4-bromo-2-chlorophenyl)-2-methylpropionitrile;
2-(4-bromo-2-chlorophenyl)-2-methylpropionitrile;
2-(4-bromo-2-fluorophenyl)-propionitrile;
1-(4-bromo-2,6-difluorophenyl)-cyclopropanecarbonitrile; and
2-(4-bromo-2,6-difluorophenyl)-2-ethylbutyronitrile.